Featured Solutions
Solving mental health challenges with evidence-based digital therapeutics
BlueKare
Korea's first digital therapeutic for depression approved by the MFDS. A personalized 8-week program helps patients manage depression and anxiety on their own in everyday life.
MHA+
A psychological assessment tool developed by Hippo T&C. Optimized questions analyze five positive indicators (stability, self-esteem, vitality, connectedness, growth) and three negative indicators (depression, anxiety, stress), then suggest tailored solutions.
CogMo Solution
A VR-based program that assesses children's cognitive and behavioral abilities through missions and applies personalized training based on the results. Children build up training effects naturally while playing.
News
Looking for partners to build the future of digital therapeutics together
We welcome collaboration with hospitals, companies, and research institutions